Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Pulse Biosciences, Inc.
pulsebiosciences.comAI Executive Summary
AI-powered analysis of 8-K filing content
Pulse Biosciences appointed Liane R. Teplitsky as Chief Operating Officer effective April 8, 2026. This strategic hire brings extensive medical device and commercialization experience from Abbott Laboratories, St. Jude Medical, and Artedrone, positioning the company to strengthen operational capabilities and advance its medical technology initiatives.
Key Takeaways
Liane R. Teplitsky appointed as new Chief Operating Officer with proven track record as CEO of Artedrone and senior roles at major medical device companies
Appointment expected to enhance operational management and strategic focus on autonomous robotic technology for stroke treatment
1 more takeaway
Related Filings (9)
9 more filings from Pulse Biosciences, Inc. in the last 90 days